These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27379831)

  • 1. Silencing of epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1 (ELTD1) via siRNA-induced cell death in glioblastoma.
    Serban F; Daianu O; Tataranu LG; Artene SA; Emami G; Georgescu AM; Alexandru O; Purcaru SO; Tache DE; Danciulescu MM; Sfredel V; Dricu A
    J Immunoassay Immunochem; 2017; 38(1):21-33. PubMed ID: 27379831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the VEGF and PDGF signaling pathway in glioblastoma treatment.
    Popescu AM; Alexandru O; Brindusa C; Purcaru SO; Tache DE; Tataranu LG; Taisescu C; Dricu A
    Int J Clin Exp Pathol; 2015; 8(7):7825-37. PubMed ID: 26339347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.
    Ziegler J; Pody R; Coutinho de Souza P; Evans B; Saunders D; Smith N; Mallory S; Njoku C; Dong Y; Chen H; Dong J; Lerner M; Mian O; Tummala S; Battiste J; Fung KM; Wren JD; Towner RA
    Neuro Oncol; 2017 Feb; 19(2):175-185. PubMed ID: 27416955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ELTD1, a potential new biomarker for gliomas.
    Towner RA; Jensen RL; Colman H; Vaillant B; Smith N; Casteel R; Saunders D; Gillespie DL; Silasi-Mansat R; Lupu F; Giles CB; Wren JD
    Neurosurgery; 2013 Jan; 72(1):77-90; discussion 91. PubMed ID: 23096411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker.
    Serban F; Artene SA; Georgescu AM; Purcaru SO; Tache DE; Alexandru O; Dricu A
    Onco Targets Ther; 2015; 8():3767-74. PubMed ID: 26719704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment.
    Ziegler J; Zalles M; Smith N; Saunders D; Lerner M; Fung KM; Patel M; Wren JD; Lupu F; Battiste J; Towner RA
    Am J Nucl Med Mol Imaging; 2019; 9(1):93-109. PubMed ID: 30911439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model.
    Zalles M; Smith N; Ziegler J; Saunders D; Remerowski S; Thomas L; Gulej R; Mamedova N; Lerner M; Fung KM; Chung J; Hwang K; Jin J; Wiley G; Brown C; Battiste J; Wren JD; Towner RA
    J Cell Mol Med; 2020 Jan; 24(2):1738-1749. PubMed ID: 31863639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of VEGFR, PDGFR and PI3K/mTOR Targeting in Glioblastoma.
    Purcaru SO; Tache DE; Serban F; Folcuti RM; Georgescu AM; Stovicek PO; Danciulescu MM; Tataranu LG; Dricu A
    Curr Health Sci J; 2015; 41(4):325-332. PubMed ID: 30538838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of ELTD1, a pro-angiogenic adhesion GPCR.
    Favara DM; Banham AH; Harris AL
    Biochem Soc Trans; 2014 Dec; 42(6):1658-64. PubMed ID: 25399586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007.
    Zalles M; Smith N; Saunders D; Lerner M; Fung KM; Battiste J; Towner RA
    J Cell Mol Med; 2022 Jan; 26(2):570-582. PubMed ID: 34910361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined inhibition of vascular endothelial growth factor receptor signaling with temozolomide enhances cytotoxicity against human glioblastoma cells via downregulation of Neuropilin-1.
    Lee J; Kim E; Ryu SW; Choi C; Choi K
    J Neurooncol; 2016 May; 128(1):29-34. PubMed ID: 26951556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELTD1-An Emerging Silent Actor in Cancer Drama Play.
    Sevastre AS; Buzatu IM; Baloi C; Oprita A; Dragoi A; Tataranu LG; Alexandru O; Tudorache S; Dricu A
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELTD1 as a multi-focal target for malignant gliomas: preclinical studies.
    Zalles M; Smith N; Saunders D; Guzman M; Lerner M; Fung KM; Babu A; Battiste J; Chung J; Hwang K; Jin J; Towner RA
    Neurooncol Adv; 2021; 3(1):vdab132. PubMed ID: 34704036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
    Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
    J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model.
    Zalles M; Smith N; Saunders D; Saran T; Thomas L; Gulej R; Lerner M; Fung KM; Chung J; Hwang K; Jin J; Battiste J; Towner RA
    Transl Oncol; 2020 Mar; 13(3):100737. PubMed ID: 32208341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effects of siRNA targeting epidermal growth factor receptor on proliferation and invasion of human glioblastoma cells].
    Kang CS; Pu PY; Wang GX; Li YH; Dong L; Wang H
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1503-8. PubMed ID: 15500708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
    Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M
    Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells.
    Palumbo S; Tini P; Toscano M; Allavena G; Angeletti F; Manai F; Miracco C; Comincini S; Pirtoli L
    J Cell Physiol; 2014 Nov; 229(11):1863-73. PubMed ID: 24691646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an ELTD1 knockout human embryonic stem cell line by the iCRISPR/Cas9 system.
    Luo Q; Wei C; Long Y; Zhang M; Shan W; Li H; Cai S; Xu Y; Qian P; Huang H
    Stem Cell Res; 2021 May; 53():102350. PubMed ID: 34087984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.